New Guidelines for Non-Alcoholic Fatty Liver Disease
6 Oct 2017
Members of The Asia-Pacific Working Party on Non-Alcoholic Fatty Liver Disease combined their expertise in drafting the most updated guidelines on NAFLD, which is going to benefit clinicians in the Asia Pacific region in managing this increasing important medical condition.
Published in two parts, “The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment” (J Gastroenterol Hepatol. 2017 Jul 3. doi: 10.1111/jgh.13857. [Epub ahead of print]) and “The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 2: Management and special groups” (J Gastroenterol Hepatol. 2017 Jul 10. doi: 10.1111/jgh.13856. [Epub ahead of print]) serve as updates to our previous guidelines dated 2007. These new guidelines reflect an improved understanding of the clinical characteristics and natural history of NAFLD and provide guidance to clinicians in the assessment and treatment of NAFLD.
Anyone interested in future collaboration in this field of research is welcome to contact our key investigators Prof Henry Chan, Head of Division of Gastroenterology and Hepatology, and Prof Vincent Wong, Professor in our Department of Medicine and Therapeutics. Prof Wong is an expert in the study of fatty liver disease and is the key investigator in the development of the therapeutics of fatty liver disease.